MXPA06005419A - Nutraceutical mangosteen tea - Google Patents

Abstract

A nutraceutical tea composition containing xanthone compounds is disclosed. The xanthones contained in the tea composition are, preferably, derived from fruit of the Garcinia mangostana L. plant, otherwise known as the mangosteen plant.

Description

TE DE MANGOSTAN NUTRACEUTICO FIELD OF THE INVENTION The present invention describes technology related to a nutraceutical tea composition comprising xanthone compo. More particularly, the present disclosed technology relates to a nutraceutical tea composition comprising xanthones derived from, for example, fruit of the plant Garcinia mangostana L., otherwise known as the plant of masgasthan.

BACKGROOF THE INVENTION Tea drinks have a long and truthful history. It is said that aro2500 a.C. Chinese Emperor Shen-Nung was one day boiling his water to drink when a few leaves of a branch fell on the container in the water. The resulting aroma was delicious, and a new beverage was born from the leaves of the wild tea plant. Tea cultivation expanded from China to Japan and finally the drink was introduced to Europe. The Boston Tea Party was a famous event at the beginning of American history that demonstrated the widespread popularity of tea drinks back then. Currently, tea is a basic drink arothe world. Many teas are known for their healthy benefits. Ref .: 173060 In fact, tea is extremely rich in chemicals called alkylamines, which has been shown to promote immune cells in the human body. Recent medical studies have indicated that teas can be positively associated with a number of health benefits, including a reduced risk of cardiovascular disease and a lower incidence of some forms of cancer. In addition, many teas are known to have high levels of antioxidants. The medicinal properties of the Garcinia Mangostana L. plant have been increasingly the subject of recent pharmacological and clinical studies. These studies have shown that some of the natural compo derived from the plant produce amazing medical benefits, especially the xanthone compo. The history of the Garcinia Mangrostana L. plant and the pharmacological benefits of the individual xanthone compo are described in a more particular detail in U.S. Pat. No. 6,730,333 (Garrity et al.) Which is incorporated herein by reference. Despite the known use of teas and the documented medicinal benefits of xanthones, there is a need in the art for a nutraceutical composition that offers the advantages of xanthone compo in a tea beverage. In addition, there is a need in the art for a tea beverage comprising natural xanthones. There is an additional need in the art for a mangosteen tea beverage that combines the benefits of the xanthone compo with the medicinal qualities of the t. There is an additional need in the art for a mangosteen tea beverage comprising the xanthones of the pericarp and the fruit pulp of the mangosteen plant.

BRIEF DESCRIPTION OF THE INVENTION The present disclosed technology relates to nutraceutical tea compositions comprising xanthone compo. In one aspect, the present disclosed technology provides a nutraceutical tea composition containing one or more ingredients selected from the group consisting of leaf teas, herbal teas, tea extracts and combinations thereof; and at least one xanthone. The nutraceutical tea composition may also contain vitamins, minerals, food grade sweeteners or a combination thereof. Preferably, the xanthones to be used in the present disclosed technology are derived from natural plant sources, especially the fruit of the Garcinia Mangostana L. plant. For example, the pericarp of the fruit of the Garcinia Mangostana L. plant can be used alone. or in combination with the pulp of the fruit to provide an excellent source of xanthones.

DETAILED DESCRIPTION OF THE INVENTION It is rstood that the terminology used herein is used for the purpose of describing only the particular embodiments, and is not intended to limit the scope of the present technology described. It is also understood that, as used herein and in the appended claims, the singular forms "a" and "an" include the plural reference, unless the context clearly dictates otherw Unless otherwdefined, all technical and scientific terms used herein have the same meanings as are commonly understood by one skilled in the art to which this invention pertains. While the different methods, compositions and materials of the present disclosed technology are described herein, any of the methods and materials similar or equivalent to those described herein, may be used in the practice and testing of the present disclosed technology. All references cited herein are incorporated by reference in their entirety. Teas are derived from a variety of different plant sources. In general, for example, there are three types of leaf teas: green tea, which is not fermented, black tea, which is slightly fermented and black or red tea, which are completely fermented. One of the main stages in the manufacture of leaf tea is the degree of fermentation of the tea leaves that they are allowed to experience. The amount of fermentation determines the type of tea that is produced. Tea fermentation usually refers to the level of enzymatic oxidation that occurs naturally when the leaves of fresh tea begin to dry. This process of natural oxidation can be stopped by frying in a pan or by steaming the tea leaves before they are completely dried. According to one embodiment of the present disclosed technology, the natural xanthones of the mangosteen plant can be combined with one or more leaf teas, herbal teas, tea extracts or a combination thereof to form a nutraceutical mangosteen tea beverage . The xanthones used in the present disclosed technology can be derived from a number of different sources. Preferably, xanthones are natural xanthones derived from the pericarp or pulp of the fruit or the complete fruit of the fruit of the Garcinia Mangostana L. plant, although other sources would also be effective. In one embodiment of the present disclosed technology, the whole mangosteen fruit is crushed into a pericarp-frit pulp mixture.

The water is then removed from the mixture by means of standard dehydration techniques well known in the industry, including vacuum dehydration. The dehydrated mixture resulting from the natural xanthones derived from the pericarp and the fruit pulp of the mangosteen fruit is an excellent source of natural, functional xanthone compounds. In another embodiment of the present disclosed technology, xanthones are extracted from a mixture of whole mangosteen fruit or the pericarp of mangosteen fruit. The synergistic effect of mangosteen xanthones with selected teas produces a nutraceutical tea beverage that offers surprising health benefits. In a further embodiment of the present disclosed technology, mangosteen xanthones are combined with rooibos tea extract. Rooibos tea comes from the plant Aspalathus linearis L. also known as Rooibos plant. This plant is part of the group of the Aspalathus plant that consists of more than 200 species that occur only in South Africa. The plant Aspalathus linearis L. is known to reduce the symptoms of insomnia, irritability, headaches, nervous tension and hypertension. It is also known to have a beneficial effect on hay fever, asthma and eczema. The combination of the xanthones of the Garcinia mangostana L. plant and the Aspalathus linearis L. plant produces a beneficial nutraceutical composition that has surprising health properties. In other embodiments of the present disclosed technology, the xanthones of the mangosteen plant are combined with one or more herbal teas selected from the group consisting of burdock, cardamom, chamomile, cinnamon, damiana, dandelion, fennel, ginger, hawthorn, kava kava, lemon balm, licorice, mint, motherwort, nettle, raspberry, rose hip, rosemary, sage, skullcap, St. John's wort, strawberry, thyme, valerian and yarrow. In a preferred embodiment of the presently described technology, a mixture of pericarp and fruit pulp of the mangosteen fruit, in a wet or dehydrated form, is mixed with the teas selected from the group consisting of burdock rooibos, cardamom, chamomile, cinnamon, damiana, dandelion, fennel, ginger, hawthorn, kava kava, lemon balm, licorice, mint, motherwort, nettle, raspberry, rose hip, rosemary, sage, skullcap, St. John's wort, strawberry, thyme, valerian and yarrow combinations thereof. The technology currently described can also be fortified with vitamins and minerals, to provide additional health and energy benefits. Although there is no limit to the type and variety of vitamins and minerals that can be employed with the technology currently described, and such knowledge is well within the realm of one skilled in the art, examples of the vitamins and minerals appropriate for the. incorporation into the compositions of the currently described technology include vitamin A, vitamin B3, vitamin B5, vitamin B6, vitamin B12, vitamin C, vitamin D, vitamin E, vitamin K, folic acid, thiamin, riboflavin, niacin, acceptable forms of biotin of pantothenic acid, calcium, sodium, potassium, phosphorus, magnesium, manganese, copper, zinc, iron, selenium, chromium and molybdenum. The currently described technology may also include food grade sweeteners, such as glucose, dextrose, fructose, lactose, maltose, xylose, sucrose, corn sugar syrup and high fructose corn syrup. The invention will now be explained with reference to the following examples, which are provided for illustration only and are not intended to limit the same.

Example 1 A mangosteen nutraceutical tea was made by diluting high fructose syrup to a Brix value of 10.38, adding vitamin C to 100% RDI for 8 ounces, adding a mixture of mangosteen pericarp and fruit pulp and adding tea extract of natural rooibos. The technology currently described can be modeled in other specific ways without departing from its spirit or essential characteristics. The described modalities will be considered in all aspects only as illustrative and not restrictive. Thus, the scope of the technology currently described is indicated by the appended claims in lieu of the above description. All changes that fall within the meaning and range of equivalency of the claims will be encompassed within its scope. It is noted that in relation to this date, the best method known to the applicant to carry out the aforementioned invention, is that which is clear from the present description of the invention.

Claims (15)

1. CLAIMS Having described the invention as above, the content of the following claims is claimed as property: 1. A nutraceutical tea composition, characterized in that it comprises: one or more ingredients selected from the group consisting of leaf teas, herbal teas, extracts of tea and combinations thereof; and at least one xanthone.
2. 2. The nutraceutical tea composition according to claim 1, characterized in that it further comprises at least one ingredient selected from the group consisting of vitamins, minerals, food grade sweeteners and combinations thereof.
3. 3. The nutraceutical tea composition according to claim 1, characterized in that at least one xanthone is derived from natural plant sources.
4. 4. The nutraceutical tea composition according to claim 1, characterized in that at least one xanthone is derived from the fruit of the plant Garcinia mangostana L.
5. 5. The nutraceutical tea composition according to claim 1, characterized in that at least one xanthone is derived from the pericarp of the fruit of the Garcinia mangostana L. plant
6. 6. The nutraceutical tea composition according to claim 1, characterized in that at least one xanthone is derived from a mixture of pulp and pericarp of fruit of the Garcinia mangostana L. plant
7. 7. The nutraceutical tea composition according to claim 1, characterized in that at least one xanthone is derived from the fruit of the Garcinia mangostana L. plant by a process comprising grinding all the fruit of the Garcinia mangostana L. plant in a mixture of pericarp and fruit pulp, where the mixture is used to make the composition of and mangosteen nutraceutical.
8. 8. The nutraceutical tea composition according to claim 7, characterized in that the mixture of pericarp and fruit pulp is dehydrated.
9. 9. The nutraceutical tea composition according to claim 1, characterized in that at least one xanthone is derived from the fruit of the Garcinia mangostana L. plant by a process comprising: grinding the whole fruit of the Garcinia mangostana L. plant. in a mixture of pericarp and fruit pulp; and extract the xanthones from the mixture.
10. 10. The nutraceutical tea composition according to claim 1, characterized in that the leaf teas are selected from the group consisting of green teas, black teas, fully fermented teas and combinations thereof.
11. 11. The nutraceutical tea composition according to claim 1, characterized in that the tea extracts are tea extracts of rooibos.
12. 12. The nutraceutical tea composition according to claim 11, characterized in that the tea extracts of rooibos are from the plant Aspalathus linearis L.
13. 13. The nutraceutical tea composition according to claim 1, characterized in that the herbal teas are select from the group consisting of burdock, cardamom, chamomile, cinnamon, damiana, dandelion, fennel, hawthorn, hawthorn, kava kava, lemon balm, licorice, mint, motherwort, nettle, raspberry, rose hip, rosemary, sage, skullcap, must of San Juan, strawberry, thyme, valerian and yarrow and combinations thereof.
14. 14. The nutraceutical tea composition according to claim 2, characterized in that the vitamins and minerals are selected from the group consisting of vitamin A, vitamin B3, vitamin B5, vitamin B6, vitamin B12, vitamin C, vitamin D, vitamin E , vitamin K, folic acid, thiamine, riboflavin, niacin, acceptable forms of biotin of pantothenic acid, calcium, sodium, potassium, phosphorus, magnesium, manganese, copper, zinc, iron, selenium, chromium and molybdenum and combinations thereof.
15. 15. The nutraceutical tea composition according to claim 2, characterized in that the food grade sweeteners are selected from the group consisting of glucose, dextrose, fructose, lactose, maltose, xylose, sucrose, corn sugar syrup, high fructose corn and combinations thereof.